University of Zurich
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1833-04-29
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uzh.ch
Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)
- Conditions
- Hypertensive Ischemic Leg UlcerCalciphylaxis
- First Posted Date
- 2012-04-16
- Last Posted Date
- 2021-06-18
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 120
- Registration Number
- NCT01578382
- Locations
- 🇨🇭
Department of Dermatology, University Hospital of Zurich, Zurich, ZH, Switzerland
Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Interventions
- Drug: Prolonged-release FampridineDrug: Placebo
- First Posted Date
- 2012-04-12
- Last Posted Date
- 2015-12-04
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 70
- Registration Number
- NCT01576354
- Locations
- 🇨🇭
University Hospital Zurich, Division of Neurology, Zurich, ZH, Switzerland
European Multicentre Study of Human Spinal Cord Injury
- Conditions
- Spinal Cord Injury
- First Posted Date
- 2012-04-05
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 8000
- Registration Number
- NCT01571531
- Locations
- 🇨🇭
University of Zurich, Zurich, Switzerland
Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D
- Conditions
- Non-alcoholic Steatohepatitis (NASH)
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-04-04
- Last Posted Date
- 2016-10-25
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 22
- Registration Number
- NCT01571063
- Locations
- 🇨🇭
University Hospital Zurich, Gastroenterology and Hepatology, Zurich, ZH, Switzerland
🇨🇭Kantonsspital St. Gallen, St. Gallen, Switzerland
Impact of Milk on Erosion/Abrasion of Enamel and Dentin - an in Situ Study
- Conditions
- Erosion Protection
- Interventions
- Other: ToothpasteDietary Supplement: MilkDietary Supplement: Fluoridated MilkDrug: Tooth MousseDrug: MI Paste PlusDrug: Elmex Erosion Protection
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 15
- Registration Number
- NCT01566357
- Locations
- 🇨🇭
Clinic for Preventive Dentistry, Periodontology and Cariology, University of Zurich, Zürich, Switzerland
Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms
- Conditions
- Overactive Bladder Syndrome
- First Posted Date
- 2012-03-21
- Last Posted Date
- 2014-12-16
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 766
- Registration Number
- NCT01559623
- Locations
- 🇨🇭
University Hospital Zurich, Gynecology, Zurich, ZH, Switzerland
Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2
- Conditions
- Missing Teeth
- Interventions
- First Posted Date
- 2012-02-29
- Last Posted Date
- 2021-12-02
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 24
- Registration Number
- NCT01541345
- Locations
- 🇦🇹
Department of Oral Surgery & Radiology, Dental School, Medical University of Graz, Graz, Austria
🇨🇭Center of Dental Medicine Clinic of Reconstructive Dentistry, Zurich, Switzerland
Lichen Planus Mucosae at USZ, Efficacy of Oral Alitretinoin
- Conditions
- Lichen Planus (LP)
- First Posted Date
- 2012-02-24
- Last Posted Date
- 2012-03-20
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 20
- Registration Number
- NCT01538732
- Locations
- 🇨🇭
University Hospital Zurich, Division of Dermatology, Zurich, ZH, Switzerland
Active Over 45: A Step-up Jogging Program in Inactive Female Hospital Staff Aged 45+
- Conditions
- Physical Activity
- Interventions
- Behavioral: step-up jogging program
- First Posted Date
- 2012-02-13
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 68
- Registration Number
- NCT01531660
- Locations
- 🇨🇭
University Hospital Zurich, Zurich, Switzerland
Controlled Level EVERolimus in Acute Coronary Syndromes
- First Posted Date
- 2012-02-09
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 150
- Registration Number
- NCT01529554
- Locations
- 🇩🇪
Kerckhoff-Klinik, Department of Cardiology, Bad Nauheim, Germany
🇨🇭University Hospital Geneva, Geneva, Switzerland
🇩🇪University Hospital Chartié, Berlin, Germany